Cargando…

Current Management Guidelines on Hyperlipidemia: The Silent Killer

Given the high incidence of cardiovascular events in the United States, strict control of modifiable risk factors is important. Pharmacotherapy is helpful in maintaining control of modifiable risk factors such as elevated lipids or hypercholesterolemia. Hypercholesterolemia can lead to atherosclerot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Lilly, Mittal, Rea, Ramgobin, Devyani, Jain, Rahul, Jain, Rohit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8363437/ https://www.ncbi.nlm.nih.gov/pubmed/34394993 http://dx.doi.org/10.1155/2021/9883352

Ejemplares similares

POCUS in Internal Medicine Curriculum: Quest for the Holy-Grail of Modern Medicine
por: Ramgobin, Devyani, et al.
Publicado: (2022)

Cardiac amyloidosis‐A review of current literature for the practicing physician
por: Ash, Samantha, et al.
Publicado: (2021)

Congestive heart failure clinics and telemedicine: The key to reducing hospital readmissions in the United States
por: Ramgobin, Devyani, et al.
Publicado: (2022)

Cardiology and COVID-19: do we have sufficient information?
por: Garg, Nikita, et al.
Publicado: (2020)

COVID-19 mental health consequences on medical students worldwide
por: Mittal, Rea, et al.
Publicado: (2021)

Papering over the cracks: COVID-19’s amplification of the failures of employer-based health insurance coverage
por: Ramgobin, Devyani, et al.
Publicado: (2021)

Gastrointestinal Manifestations of COVID-19: A Review of What We Know
por: Groff, Andrew, et al.
Publicado: (2021)

Hyperlipidemia: An Evidence-based Review of Current Guidelines
por: Clebak, Karl T, et al.
Publicado: (2020)

Inflammation in Urological Malignancies: The Silent Killer
por: Catalano, Martina, et al.
Publicado: (2023)

Aluminum environmental pollution: the silent killer
por: Alasfar, Reema H., et al.
Publicado: (2021)

Coronavirus as silent killer: recent advancement to pathogenesis, therapeutic strategy and future perspectives
por: Raj, Khadga, et al.
Publicado: (2020)

Conquering the Silent Killer: Hypertension Prevention and Management in India
por: Kotwal, Atul, et al.
Publicado: (2023)

Palatal Melanoma: “The Silent Killer”
por: Tchernev, Georgi, et al.
Publicado: (2018)

Could dopamine be a silent killer?
por: Azarov, Nick, et al.
Publicado: (2007)

Multimodality Imaging of a Silent Killer
por: Abdelkarim, Ola, et al.
Publicado: (2022)

Unpacking the Complexities of a Silent Killer
por: Yamanouchi, Dai
Publicado: (2023)

Aluminium(III) Oxide—The Silent Killer of Bacteria
por: Schabikowski, Mateusz, et al.
Publicado: (2023)

Liquid biopsy in ovarian cancer: Catching the silent killer before it strikes
por: Feeney, Laura, et al.
Publicado: (2020)

Practical guidelines for familial combined hyperlipidemia diagnosis: an up-date
por: Gaddi, Antonio, et al.
Publicado: (2007)

Melanoma of the oral cavity: A silent killer
por: Aloua, Rachid, et al.
Publicado: (2021)

Small Fiber Neuropathy Associated with Hyperlipidemia: Utility of Cutaneous Silent Periods and Autonomic Tests
por: Morkavuk, G., et al.
Publicado: (2014)

Airway closure: the silent killer of peripheral airways
por: Pelosi, Paolo, et al.
Publicado: (2007)

Oral malignant melanoma: A silent killer?
por: Padhye, Ashvini, et al.
Publicado: (2011)

Who is the guilty among these two silent killers?
por: Martini, Bortolo, et al.
Publicado: (2016)

Postprandial Hypotension: An Underreported Silent Killer in the Aged
por: Awosika, Ayoola, et al.
Publicado: (2023)

FRI231 Pheochromocytoma - A Silent Killer
por: Le, Kelly, et al.
Publicado: (2023)

Cough syrups: silent killer of Gambian children
por: Chopra, Hitesh, et al.
Publicado: (2023)

Pulmonary embolism in coronavirus disease 2019: the silent killer
por: Marwah, Vikas, et al.
Publicado: (2021)

Management of hyperlipidemia with statins in the older patient
por: Aronow, Wilbert S
Publicado: (2006)

Comparative Effectiveness of Guidelines for the Management of Hyperlipidemia and Hypertension for Type 2 Diabetes Patients
por: Shah, Nilay D., et al.
Publicado: (2011)

Atheroembolic kidney disease: The under‐recognized silent killer
por: Ștefan, Gabriel, et al.
Publicado: (2021)

How can gynaecologists cope with the silent killer – osteoporosis?
por: Szamatowicz, Marian
Publicado: (2017)

The increasing rate of diabetes in Pakistan: A silent killer
por: Azeem, Saleha, et al.
Publicado: (2022)

New Year's silent killer in Japan: Undigested mochi
por: Kawanishi, Koki, et al.
Publicado: (2022)

Management Algorithm for Subclinical Hypoxemia in Coronavirus Disease-2019 Patients: Intercepting the “Silent Killer”
por: Galwankar, Sagar C., et al.
Publicado: (2020)

Mucormycosis in COVID-19: Is Zinc a Silent Killer in India?
por: Nath, Sayan, et al.
Publicado: (2021)

Silent Killer: Case Report of Acute Gastrostomy Tube Erosion
por: Chang, Allen D., et al.
Publicado: (2015)

Carbon monoxide: raising awareness of the silent killer in the emergency department
por: Malik, Fahad Siddique, et al.
Publicado: (2022)

Monogenic hyperlipidemias
por: Krasi, Geraldo, et al.
Publicado: (2019)

From the “Silent Killer” to the “Whispering Disease”: Ovarian Cancer and the Uses of Metaphor
por: JASEN, PATRICIA
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_glih88qu7724ausvht6kfdomd2